These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26994376)

  • 1. Improving global vaccine accessibility.
    Hill AB; Kilgore C; McGlynn M; Jones CH
    Curr Opin Biotechnol; 2016 Dec; 42():67-73. PubMed ID: 26994376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs of vaccine programs across 94 low- and middle-income countries.
    Portnoy A; Ozawa S; Grewal S; Norman BA; Rajgopal J; Gorham KM; Haidari LA; Brown ST; Lee BY
    Vaccine; 2015 May; 33 Suppl 1():A99-108. PubMed ID: 25919184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Financing of vaccines.
    Barton JH
    Lancet; 2000 Apr; 355(9211):1269-70. PubMed ID: 10770320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strengthening vaccination policies in Latin America: an evidence-based approach.
    Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
    Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The U.S. vaccine and immunization enterprise: Working to sustain and foster vaccine innovation.
    Shen AK
    Hum Vaccin; 2009 Oct; 5(10):649-53. PubMed ID: 19713758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of antigens used for vaccination: recent advances and challenges.
    Scherliess R
    Ther Deliv; 2011 Oct; 2(10):1351-68. PubMed ID: 22826888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strengthening global vaccine access for adolescents and adults.
    Nanni A; Meredith S; Gati S; Holm K; Harmon T; Ginsberg A
    Vaccine; 2017 Dec; 35(49 Pt B):6823-6827. PubMed ID: 29122384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges for nationwide vaccine delivery in African countries.
    Songane M
    Int J Health Econ Manag; 2018 Jun; 18(2):197-219. PubMed ID: 29047019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reaching more children with vaccines in developing countries: key challenges of innovation and delivery.
    Popova O; Ibarra de Palacios P
    Curr Med Res Opin; 2016; 32(1):177-81. PubMed ID: 26471345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral vaccines: new needs, new possibilities.
    Aziz MA; Midha S; Waheed SM; Bhatnagar R
    Bioessays; 2007 Jun; 29(6):591-604. PubMed ID: 17508389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A strategic approach to vaccine development: animal models, monitoring vaccine efficacy, formulation and delivery.
    Griffin JF
    Adv Drug Deliv Rev; 2002 Oct; 54(6):851-61. PubMed ID: 12363434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What have we learned on costs and financing of routine immunization from the comprehensive multi-year plans in GAVI eligible countries?
    Brenzel L
    Vaccine; 2015 May; 33 Suppl 1():A93-8. PubMed ID: 25919183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examining the cost of delivering routine immunization in Honduras.
    Janusz CB; Castañeda-Orjuela C; Molina Aguilera IB; Felix Garcia AG; Mendoza L; Díaz IY; Resch SC
    Vaccine; 2015 May; 33 Suppl 1():A53-9. PubMed ID: 25919175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The introduction of new vaccines into developing countries. IV: Global Access Strategies.
    Mahoney RT; Krattiger A; Clemens JD; Curtiss R
    Vaccine; 2007 May; 25(20):4003-11. PubMed ID: 17363119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccines as a global imperative--a business perspective.
    Stéphenne J
    Health Aff (Millwood); 2011 Jun; 30(6):1042-8. PubMed ID: 21653955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine adjuvant properties of probiotic bacteria.
    Licciardi PV; Tang ML
    Discov Med; 2011 Dec; 12(67):525-33. PubMed ID: 22204769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissolving Microneedle Patches for Dermal Vaccination.
    Leone M; Mönkäre J; Bouwstra JA; Kersten G
    Pharm Res; 2017 Nov; 34(11):2223-2240. PubMed ID: 28718050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Closing the global immunization gap: delivery of lifesaving vaccines through innovation and technology.
    Desai SN; Kamat D
    Pediatr Rev; 2014 Jul; 35(7):e32-40. PubMed ID: 24986933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine strategies: Optimising outcomes.
    Hardt K; Bonanni P; King S; Santos JI; El-Hodhod M; Zimet GD; Preiss S
    Vaccine; 2016 Dec; 34(52):6691-6699. PubMed ID: 27887796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal delivery of vaccine antigens and its advantages in pediatrics.
    De Magistris MT
    Adv Drug Deliv Rev; 2006 Apr; 58(1):52-67. PubMed ID: 16516335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.